Serum ferritin levels in children with dengue infection

Wathanee Chaiyaratana1, Ampaiwan Chuansumrit, Kalayanee Atamasirikul

  • 1Research Center, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. rawcy@mahidol.ac.th

Insights

Elevated serum ferritin levels may predict dengue hemorrhagic fever (DHF) risk in children. This study found higher ferritin in DHF patients, suggesting its potential as a diagnostic marker for severe dengue infection.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Biochemistry

Background:

  • Dengue infection is a significant public health concern, with dengue hemorrhagic fever (DHF) representing a severe form.
  • Early identification of DHF risk is crucial for timely intervention and improved patient outcomes.
  • Ferritin, an acute-phase reactant, has been investigated for its role in various inflammatory conditions.

Purpose of the Study:

  • To evaluate the predictive value of serum ferritin levels for the risk of developing dengue hemorrhagic fever (DHF) in children with dengue infection.
  • To compare serum ferritin levels between children with dengue fever (DF) and DHF.

Main Methods:

  • A cohort of 177 Thai children (aged 4-16 years) diagnosed with dengue infection (DF or DHF) were enrolled.
  • Serum ferritin levels were measured daily during hospitalization and post-discharge.
  • Statistical analysis was performed to compare ferritin levels and determine predictive accuracy for DHF.

Main Results:

  • Children with DHF exhibited significantly higher median serum ferritin levels compared to those with DF, particularly on days 5, 6, and 7 of illness (p<0.05).
  • A serum ferritin cutoff level of 1,200 ng/ml demonstrated high sensitivity (81.5-89.9%) for predicting DHF on days 5-7.
  • Specificities for predicting DHF at this cutoff ranged from 36.4% to 42.4% on days 5-7.

Conclusions:

  • Elevated serum ferritin levels, especially above 1,200 ng/ml, may serve as a potential predictor for dengue hemorrhagic fever in children.
  • Further research is warranted to validate ferritin as a reliable biomarker for DHF risk stratification.